Table 2.
Individual and mean pharmacokinetic parameters of ceftazidime
Pharmacokinetic parameters | Css | AUC0–72 | CLtot | Vd | T1/2 |
Patient 1 | 35.2 | 2625.0 | 59.2 | 19.0 | 3.7 |
Patient 2 | 34.3 | 2655.0 | 60.8 | 12.4 | 2.8 |
Patient 3 | 28.8 | 2146.0 | 72.3 | 17.7 | 2.8 |
Patient 4 | 32.5 | 2372.0 | 64.1 | 29.4 | 5.3 |
Patient 5 | 36.3 | 2795.0 | 57.5 | 24.1 | 5.0 |
Patient 6 | 33.6 | 2471.0 | 62.0 | 13.7 | 2.6 |
Patient 7 | 34.2 | 2536.0 | 61.0 | 15.8 | 3.0 |
Mean | 33.5 | 2514.3 | 62.4 | 18.9 | 3.6 |
Standard deviation | 2.4 | 211.8 | 4.8 | 6.0 | 1.1 |
AUC0–72 h, area under the concentration time-curve from time zero to 72 hours (mg/hour per l); CLtot, total clearance of ceftazidime (ml/min); Css, steady-state serum ceftazidime concentration (mg/l); T1/2, elimination half-life (hours); Vd, volume of distribution (l).